August 2019 in “The journal of investigative dermatology/Journal of investigative dermatology” This study concluded that placebo effects observed in older alopecia minoxidil studies are likely due to subjective hair count assessments and study design, rather than true improvements in hair growth.
5 citations
,
December 2020 in “Journal of The American Academy of Dermatology” This study observed objective improvement in androgenetic alopecia in 5 out of 6 adolescent girls treated with 2.5 mg oral minoxidil and spironolactone, and reported no adverse effects.
14 citations
,
April 1987 in “PubMed” In an open trial, 2.8% minoxidil solution applied topically stimulated new hair growth in 45% of male patients with male pattern alopecia, though patient self-assessments were more favorable than objective evaluations.
29 citations
,
May 2010 in “Annals of Pharmacotherapy” This review discusses the limited objective evidence for using finasteride in women with alopecia, suggesting that it could be considered for those who don't benefit from minoxidil, but reports no new clinical results.
May 2022 in “Journal of The American Academy of Dermatology” This systematic review reported objective clinical improvement with low-dose oral minoxidil in up to 100% of patients with androgenetic alopecia and up to 82.4% with alopecia areata.